31 biopharmas at high risk of bankruptcy in 2020

31 biopharmas at high risk of bankruptcy in 2020

Submitted by admin on November 20, 2019 - 10:18am
Source: 
Biopharma Dive
News Tags: 
bankruptcy
Teva Pharmaceutical
Bausch Health
Novavax
Headline: 
31 biopharmas at high risk of bankruptcy in 2020
snippet: 

BioPharma Dive dug into data from a credit monitoring firm to identify drugmakers at high risk of going bankrupt, including companies like Teva, Bausch Health and Novavax.

Do Not Allow Advertisers to Use My Personal information